Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Chemotherapy with CDDP/5-FU with vs without Immunorestorative Therapy with DTC in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								MDA-DM-8523 NCI-V85-0245

Last Modified: 12/1/1987


2.		Phase II Pilot Study of Toxicity Attenuation with Diethyldithiocarbamate in Patients with Epithelial Ovarian Cancer Receiving High-Dose CACP or High-Dose CBDCA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				18 and over				NCI				NCI-87-C-18B NCI-T87-0055N, T87-0055

Last Modified: 10/1/1989


3.		Phase II Limited Study of Diethyldithiocarbamate to Protect Against CDDP/CTX-Induced Toxicity in Patients with Advanced Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				18 and over								MSKCC-89022 NCI-V89-0109

Last Modified: 9/1/1991


4.		Phase II Study of Second-Line CBDCA with DTC Used as a Bone Marrow Protective Agent in Patients with Ovarian or Fallopian Tube Cancer or Adenocarcinoma of the Peritoneum who have Previously Responded to CDDP- or CBDCA-based Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				18 and over								MSKCC-91049 NCI-V91-0119

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute